Challenges of implementing new remineralization technologies.
Pfarrer
A M
AM
3M ESPE Preventive Care, St Paul, MN 55116, USA. ampfarrer@mmm.com
Karlinsey
R L
RL
D000826:Animal Testing Alternatives; D000818:Animals; D002327:Cariostatic Agents / Q000191:economics / Q000494:pharmacology*; D002986:Clinical Trials as Topic; D057186:Comparative Effectiveness Research; D003627:Data Interpretation, Statistical; D003731:Dental Caries / Q000517:prevention & control*; D017277:Drug Approval; D004339:Drug Compounding; D004344:Drug Incompatibility; D005459:Fluorides / Q000494:pharmacology; D006801:Humans; D040541:Marketing / Q000191:economics; D014089:Tooth Remineralization / Q000379:methods*
D002327:Cariostatic Agents; D005459:Fluorides